29 results
8-K
EX-99.1
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
Controller from January 1, 2021, to January 17, 2024. Mr. Ohrt has spent the last 35 years in various financial leadership roles, including serving … to the Vitro family.”
“I’m excited to accept this leadership role at Vitro,” said Mr. Ohrt. “The company’s products hold remarkable promise across a variety
10-12G/A
6wicc75zl9sc 3v8w2
21 Dec 22
Registration of securities (amended)
4:50pm
10-12G/A
qk80hu7otxeaze8o3
4 Nov 22
Registration of securities (amended)
3:29pm
S-1/A
s8ujb 1jhevt
3 Nov 22
IPO registration (amended)
5:28pm
10-12G
EX-99.1
t9rn d0yv2kt
9 Sep 22
Registration of securities
9:46pm
S-1
wq3d7 kltpdxbh
9 Sep 22
IPO registration
5:13pm
S-1
EX-24
nznks
9 Sep 22
IPO registration
5:13pm
8-K
EX-99.1
iixwzp er4m
5 Oct 20
Vitro Biopharma 3rd Quarter ended July 31st 2020 Financial Results of Operations
5:20pm
8-K
EX-99.1
val8v7bz6 p6mbwxtgji
9 Jul 20
Vitro Biopharma 2nd Quarter ended April 30th 2020 Financial Results of Operations
12:23pm
8-K
EX-99.1
35smyg7
4 Jun 20
Vitro Biopharma Signs MOU with GIOSTAR for COVID-19 IND Using AlloRx Stem Cells
2:41pm
8-K/A
EX-99.1
2r3pdy
4 Feb 20
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.2
kjvdyw7mcd5r
27 Jan 20
Results of Operations and Financial Condition
3:19pm